Call For Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to Recognise Exceptional Reporting on Epilepsy

Description

Call For Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to Recognise Exceptional Reporting on Epilepsy PR Newswire SLOUGH, England, June 12, 2012 SLOUGH, England, June 12, 2012 /PRNewswire/ -- Today marks the launch of the 2012 Excellence in Epilepsy Journalism Award that aims to raise awareness about epilepsy across the globe. The award is a joint initiative of the International Bureau for Epilepsy and biopharmaceutical company UCB and recognises journalists who have excelled in reporting on this often-misunderstood condition. Epilepsy is the most common, serious neurological condition, affecting nearly [1]50 million people worldwide. Now in its fourth year, the annual Excellence in Epilepsy Journalism Award recognises original and informative reporting on epilepsy, attracting a growing number of high-quality entries from around the world, with 49 entries from 24 countries received last year. "Despite advances in the understanding and treatment of epilepsy, many people living with epilepsy continue to face prejudice and ignorance. By recognising remarkable, thought-provoking and most importantly accurate journalism, we can help to increase understanding of the condition and continue the IBE's mission to improve the quality of life of all people with epilepsy and their families," commented Mike Glynn, award judge and President of IBE.

Informations

• Publié par: ucb
• Nombre de lectures: 14
• Langue: English

Extrait

Call For Entries: International Bureau for

Epilepsy and UCB launch the 2012 Excellence

in Epilepsy Journalism Award to Recognise

Exceptional Reporting on Epilepsy

PR Newswire

SLOUGH, England, June 12, 2012

SLOUGH, England

,

June 12, 2012

/PRNewswire/ --

Today marks the launch of the 2012 Excellence in Epilepsy Journalism Award

that aims to raise awareness about epilepsy across the globe. The award is a

joint initiative of the International Bureau for Epilepsy and biopharmaceutical

company UCB and recognises journalists who have excelled in reporting on this

often-misunderstood condition.

Epilepsy is the most common, serious neurological condition, affecting nearly

50 million people worldwide.

[1]

Now in its fourth year, the annual Excellence in

Epilepsy Journalism Award recognises original and informative reporting on

epilepsy, attracting a growing number of high-quality entries from around the

world, with 49 entries from 24 countries received last year.

"Despite advances in the understanding and treatment of epilepsy, many

people living with epilepsy continue to face prejudice and ignorance. By

recognising remarkable, thought-provoking and most importantly accurate

journalism, we can help to increase understanding of the condition and

continue the IBE's mission to improve the quality of life of all people with

epilepsy and their families," commented Mike Glynn, award judge and President

of IBE.

"At UCB we have a passion for enabling people with epilepsy to enjoy normal

everyday lives. We are committed to improving the lives of people with epilepsy

worldwide, and our support of the Excellence in Epilepsy Journalism Award

supports education and acceptance of the condition," said Lode Dewulf, MD,

Vice President, Global Medical Affairs, UCB.

The Excellence in Epilepsy Journalism Award is open to all journalists, across

four categories - print, online, broadcast TV and broadcast radio, with one

winner selected from each group. Entries can either be entered by the author

or via nomination by a third party. An independent panel of media experts and

people with experience of epilepsy will judge submitted entries against set

criteria. The panel will select winning entries that are informative, original,

responsible and support the aim of raising awareness and understanding of

epilepsy.

Entries can be about any aspect of epilepsy and must have been published or

broadcast between

30th November 2011

and 30

th

November 2012

.

2011 print winner Maj My Midtgaard Humaidan said: "I was honoured to receive

this award. My article focused on the challenges people with epilepsy and their

families face, exploring the realities of living day-to-day with this condition. I

hope to continue to increase understanding and awareness of epilepsy."

Jessica Solodar, 2010 online winner for her epilepsy.com article, Seizures

triggered by video games: Underestimated and undiagnosed, commented: "I

was pleased to be recognised for my article on photosensitive epilepsy because

the award has helped draw attention to this important issue. There is a

tremendous need for more awareness and understanding of epilepsy, and I

hope this award encourages more journalists to write about it."

Aliyah Baruchin, 2009 online and print winner said: "I was delighted to be

awarded the 2009 Excellence in Epilepsy Journalism Award. I am very glad that

my article,

'Epilepsy in the African-American Community: Access Education and

Advocacy'

- published in EpilepsyUSA - has increased awareness of the

challenges often faced by the African-American community when trying to gain

access to appropriate epilepsy care. The 2009 award allowed me to do

additional reporting and writing - including an article on epilepsy in

West Africa

-

that can help to de-stigmatise epilepsy and give a voice to those who live with

it."

Notes to editors

To find out more information or to download an entry or nomination form, please visit:

http://www.ibe-epilepsy.org

or

http://www.ucbpharma.co.uk

Certain local restrictions may apply regarding this award and the award is only

available where not prohibited or restricted by local laws and regulations.

About the IBE

Founded almost 50 years ago, the IBE is an organisation of laypersons and

professionals interested in the medical and non-medical aspects of epilepsy.

The IBE addresses such social problems as education, employment, insurance,

driving licence restrictions and public awareness, and supports its members

through a range of innovative and important initiatives aimed at improving the

quality of life of people with epilepsy and their families. http://www.ibe-

epilepsy.org

About UCB

UCB, Brussels, Belgium is a biopharmaceutical company dedicated to the

research, development and commercialization of innovative medicines with a

focus on the fields of central nervous system and immunology disorders.

Forward looking statement

This press release contains forward-looking statements based on current plans,

estimates and beliefs of management. Such statements are subject to risks and

uncertainties that may cause actual results to be materially different from

those that may be implied by such forward-looking statements contained in this

press release. Important factors that could result in such differences include:

changes in general economic, business and competitive conditions, effects of

future judicial decisions, changes in regulation, exchange rate fluctuations and

hiring and retention of its employees.

References

1.

http://www.who.int/mediacentre/factsheets/fs999/en/

[last accessed 28th May

2012]

May 2012

UK/12MIS0053